China startup finds growth with $765 cancer-screening kit

Genetron rides COVID tailwind as health awareness rises and population ages

20201222 genetron tweaked

Genetron has developed easy-to-use cancer screening test kits, which can be purchased on e-commerce sites. (Source photos by Daiki Katagiri and Genetron Health)

YUSUKE HINATA, Nikkei staff writer

GUANGZHOU, China -- A Chinese startup that provides cancer risk diagnosis and other services is showing rapid growth as the country's aging population, shocked by the novel coronavirus, is beginning to take its health more seriously.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.